| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| April 17th, 2006 | 28 | Yes |
Popular Name: ABT-869 ABT-869
Find On: PubMed — Wikipedia — Google
CAS Numbers: 796967-16-3 , [796967-16-3]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea
796967-16-3; D09635; Linifanib (USAN/INN)
ABT869, Linifanib, AL-39324, RG3635
N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea
N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
Urea, N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)-
Urea, N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)-
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.73 | 7.88 | -12.09 | 5 | 6 | 0 | 96 | 375.407 | 3 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Target | PDGFR, VEGFR | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
| ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
| AURKA-2-E | Serine/threonine-protein Kinase Aurora-A (cluster #2 Of 3), Eukaryotic | Eukaryotes | 760 | 0.31 | Binding ≤ 10μM |
| AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 390 | 0.32 | Binding ≤ 10μM |
| AURKC-2-E | Serine/threonine-protein Kinase Aurora-C (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.36 | Binding ≤ 10μM |
| BMPR2-1-E | Bone Morphogenetic Protein Receptor Type-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7800 | 0.26 | Binding ≤ 10μM |
| CD11A-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.30 | Binding ≤ 10μM |
| CD11B-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
| CDK1-3-E | Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 9800 | 0.25 | Binding ≤ 10μM |
| CDK19-1-E | Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 74 | 0.36 | Binding ≤ 10μM |
| CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.28 | Binding ≤ 10μM |
| CDK8-1-E | Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 95 | 0.35 | Binding ≤ 10μM |
| CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3000 | 0.28 | Binding ≤ 10μM |
| CLK1-2-E | Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM |
| CLK4-2-E | Dual Specificity Protein Kinase CLK4 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
| CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
| DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 58 | 0.36 | Binding ≤ 10μM |
| DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3800 | 0.27 | Binding ≤ 10μM |
| EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 6500 | 0.26 | Binding ≤ 10μM |
| EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3500 | 0.27 | Binding ≤ 10μM |
| EPHA6-1-E | Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.32 | Binding ≤ 10μM |
| EPHB3-1-E | Ephrin Type-B Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
| EPHB4-1-E | Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.40 | Binding ≤ 10μM |
| FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.32 | Binding ≤ 10μM |
| INSRR-1-E | Insulin Receptor-related Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3900 | 0.27 | Binding ≤ 10μM |
| KAPCA-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic | Eukaryotes | 6900 | 0.26 | Binding ≤ 10μM |
| KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 81 | 0.35 | Binding ≤ 10μM |
| KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7200 | 0.26 | Binding ≤ 10μM |
| KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1200 | 0.30 | Binding ≤ 10μM |
| LATS2-1-E | Serine/threonine-protein Kinase LATS2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
| LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4700 | 0.27 | Binding ≤ 10μM |
| LTK-1-E | Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 550 | 0.31 | Binding ≤ 10μM |
| M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 830 | 0.30 | Binding ≤ 10μM |
| M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3200 | 0.27 | Binding ≤ 10μM |
| M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 910 | 0.30 | Binding ≤ 10μM |
| MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 870 | 0.30 | Binding ≤ 10μM |
| MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
| MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 240 | 0.33 | Binding ≤ 10μM |
| MK15-1-E | Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
| MKNK1-1-E | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4900 | 0.27 | Binding ≤ 10μM |
| MKNK2-1-E | MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 270 | 0.33 | Binding ≤ 10μM |
| MUSK-1-E | Muscle, Skeletal Receptor Tyrosine Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
| NTRK1-1-E | Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
| NTRK2-1-E | Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
| NTRK3-1-E | NT-3 Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.33 | Binding ≤ 10μM |
| PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4 | 0.42 | Binding ≤ 10μM |
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 66 | 0.36 | Binding ≤ 10μM |
| PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8500 | 0.25 | Binding ≤ 10μM |
| RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.29 | Binding ≤ 10μM |
| RIPK1-1-E | Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
| SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 450 | 0.32 | Binding ≤ 10μM |
| ST32B-1-E | Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 270 | 0.33 | Binding ≤ 10μM |
| STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 460 | 0.32 | Binding ≤ 10μM |
| STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.29 | Binding ≤ 10μM |
| STK33-1-E | Serine/threonine-protein Kinase 33 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3800 | 0.27 | Binding ≤ 10μM |
| STK4-2-E | Serine/threonine-protein Kinase MST1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
| TIE1-1-E | Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.35 | Binding ≤ 10μM |
| TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 450 | 0.32 | Binding ≤ 10μM |
| UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 340 | 0.32 | Binding ≤ 10μM |
| VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Binding ≤ 10μM |
| VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 8 | 0.40 | Binding ≤ 10μM |
| VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 190 | 0.34 | Binding ≤ 10μM |
| VGFR2-2-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4 | 0.42 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 240 | 0.33 | Binding ≤ 1μM |
| CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 74 | 0.36 | Binding ≤ 1μM |
| CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 95 | 0.35 | Binding ≤ 1μM |
| EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 330 | 0.32 | Binding ≤ 1μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 58 | 0.36 | Binding ≤ 1μM |
| LTK_HUMAN | P29376 | Leukocyte Tyrosine Kinase Receptor, Human | 550 | 0.31 | Binding ≤ 1μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 3 | 0.43 | Binding ≤ 1μM |
| MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 270 | 0.33 | Binding ≤ 1μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 830 | 0.30 | Binding ≤ 1μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 910 | 0.30 | Binding ≤ 1μM |
| MUSK_HUMAN | O15146 | Muscle, Skeletal Receptor Tyrosine Protein Kinase, Human | 10 | 0.40 | Binding ≤ 1μM |
| NTRK3_HUMAN | Q16288 | NT-3 Growth Factor Receptor, Human | 210 | 0.33 | Binding ≤ 1μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 4.2 | 0.42 | Binding ≤ 1μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 1.9 | 0.44 | Binding ≤ 1μM |
| MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 870 | 0.30 | Binding ≤ 1μM |
| STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 460 | 0.32 | Binding ≤ 1μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 450 | 0.32 | Binding ≤ 1μM |
| ST32B_HUMAN | Q9NY57 | Serine/threonine-protein Kinase 32B, Human | 270 | 0.33 | Binding ≤ 1μM |
| AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 760 | 0.31 | Binding ≤ 1μM |
| AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 390 | 0.32 | Binding ≤ 1μM |
| AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 71 | 0.36 | Binding ≤ 1μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 1.7 | 0.44 | Binding ≤ 1μM |
| FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 400 | 0.32 | Binding ≤ 1μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 0.63 | 0.46 | Binding ≤ 1μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 100 | 0.35 | Binding ≤ 1μM |
| TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 110 | 0.35 | Binding ≤ 1μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 340 | 0.32 | Binding ≤ 1μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 170 | 0.34 | Binding ≤ 1μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 3 | 0.43 | Binding ≤ 1μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 28 | 0.38 | Binding ≤ 1μM |
| VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 16 | 0.39 | Binding ≤ 1μM |
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 1600 | 0.29 | Binding ≤ 10μM |
| BMPR2_HUMAN | Q13873 | Bone Morphogenetic Protein Receptor Type-2, Human | 7800 | 0.26 | Binding ≤ 10μM |
| MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 240 | 0.33 | Binding ≤ 10μM |
| KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 6900 | 0.26 | Binding ≤ 10μM |
| CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 74 | 0.36 | Binding ≤ 10μM |
| CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 95 | 0.35 | Binding ≤ 10μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 9800 | 0.25 | Binding ≤ 10μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 2900 | 0.28 | Binding ≤ 10μM |
| CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 3000 | 0.28 | Binding ≤ 10μM |
| DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 3800 | 0.27 | Binding ≤ 10μM |
| CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 1600 | 0.29 | Binding ≤ 10μM |
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 8900 | 0.25 | Binding ≤ 10μM |
| EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 3500 | 0.27 | Binding ≤ 10μM |
| EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 330 | 0.32 | Binding ≤ 10μM |
| EPHB3_HUMAN | P54753 | Ephrin Type-B Receptor 3, Human | 1400 | 0.29 | Binding ≤ 10μM |
| EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 1400 | 0.29 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 6500 | 0.26 | Binding ≤ 10μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 58 | 0.36 | Binding ≤ 10μM |
| MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 1300 | 0.29 | Binding ≤ 10μM |
| INSRR_HUMAN | P14616 | Insulin Receptor-related Protein, Human | 3900 | 0.27 | Binding ≤ 10μM |
| LTK_HUMAN | P29376 | Leukocyte Tyrosine Kinase Receptor, Human | 550 | 0.31 | Binding ≤ 10μM |
| LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 4700 | 0.27 | Binding ≤ 10μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 3 | 0.43 | Binding ≤ 10μM |
| MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 270 | 0.33 | Binding ≤ 10μM |
| MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 4900 | 0.27 | Binding ≤ 10μM |
| MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 2800 | 0.28 | Binding ≤ 10μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 830 | 0.30 | Binding ≤ 10μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 3200 | 0.27 | Binding ≤ 10μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 910 | 0.30 | Binding ≤ 10μM |
| MUSK_HUMAN | O15146 | Muscle, Skeletal Receptor Tyrosine Protein Kinase, Human | 10 | 0.40 | Binding ≤ 10μM |
| NTRK1_HUMAN | P04629 | Nerve Growth Factor Receptor Trk-A, Human | 3100 | 0.28 | Binding ≤ 10μM |
| NTRK2_HUMAN | Q16620 | Neurotrophic Tyrosine Kinase Receptor Type 2, Human | 1100 | 0.30 | Binding ≤ 10μM |
| NTRK3_HUMAN | Q16288 | NT-3 Growth Factor Receptor, Human | 210 | 0.33 | Binding ≤ 10μM |
| CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 1300 | 0.29 | Binding ≤ 10μM |
| CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 1200 | 0.30 | Binding ≤ 10μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 4.2 | 0.42 | Binding ≤ 10μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 1.9 | 0.44 | Binding ≤ 10μM |
| MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 870 | 0.30 | Binding ≤ 10μM |
| RIPK1_HUMAN | Q13546 | Receptor-interacting Serine/threonine-protein Kinase 1, Human | 2800 | 0.28 | Binding ≤ 10μM |
| KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 7200 | 0.26 | Binding ≤ 10μM |
| KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 1200 | 0.30 | Binding ≤ 10μM |
| STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 460 | 0.32 | Binding ≤ 10μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 450 | 0.32 | Binding ≤ 10μM |
| ST32B_HUMAN | Q9NY57 | Serine/threonine-protein Kinase 32B, Human | 270 | 0.33 | Binding ≤ 10μM |
| STK33_HUMAN | Q9BYT3 | Serine/threonine-protein Kinase 33, Human | 3800 | 0.27 | Binding ≤ 10μM |
| AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 1600 | 0.29 | Binding ≤ 10μM |
| AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 390 | 0.32 | Binding ≤ 10μM |
| AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 71 | 0.36 | Binding ≤ 10μM |
| LATS2_HUMAN | Q9NRM7 | Serine/threonine-protein Kinase LATS2, Human | 1700 | 0.29 | Binding ≤ 10μM |
| STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 1400 | 0.29 | Binding ≤ 10μM |
| STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 1500 | 0.29 | Binding ≤ 10μM |
| PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 8500 | 0.25 | Binding ≤ 10μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 1.7 | 0.44 | Binding ≤ 10μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1700 | 0.29 | Binding ≤ 10μM |
| FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 400 | 0.32 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 0.63 | 0.46 | Binding ≤ 10μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 100 | 0.35 | Binding ≤ 10μM |
| TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 110 | 0.35 | Binding ≤ 10μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 340 | 0.32 | Binding ≤ 10μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 170 | 0.34 | Binding ≤ 10μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 3 | 0.43 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 28 | 0.38 | Binding ≤ 10μM |
| VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 16 | 0.39 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 4 | 0.42 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Activation of the AP-1 family of transcription factors | |
| APC/C:Cdc20 mediated degradation of Cyclin B | |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
| ARMS-mediated activation | |
| Caspase-8 activation by cleavage | |
| CDO in myogenesis | |
| Cell surface interactions at the vascular wall | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Condensation of Prometaphase Chromosomes | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of Adenylate Cyclase | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin B2 mediated events | |
| Cyclin D associated events in G1 | |
| Cyclin E associated events during G1/S transition | |
| DARPP-32 events | |
| Depolymerisation of the Nuclear Lamina | |
| Dimerization of procaspase-8 | |
| Downstream signal transduction | |
| Dual incision reaction in GG-NER | |
| Dual incision reaction in TC-NER | |
| E2F mediated regulation of DNA replication | |
| E2F-enabled inhibition of pre-replication complex formation | |
| ECM proteoglycans | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| ERK/MAPK targets | |
| ERK1 activation | |
| Factors involved in megakaryocyte development and platelet production | |
| FCERI mediated MAPK activation | |
| Formation of HIV elongation complex in the absence of HIV Tat | |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | |
| Formation of incision complex in GG-NER | |
| Formation of RNA Pol II elongation complex | |
| Formation of the Early Elongation Complex | |
| Formation of the HIV-1 Early Elongation Complex | |
| Formation of transcription-coupled NER (TC-NER) repair complex | |
| Frs2-mediated activation | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2/M DNA replication checkpoint | |
| GAB1 signalosome | |
| Generic Transcription Pathway | |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
| Gluconeogenesis | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| HIV elongation arrest and recovery | |
| HIV Transcription Initiation | |
| Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |
| IKK complex recruitment mediated by RIP1 | |
| Integrin cell surface interactions | |
| Interactions of Tat with host cellular proteins | |
| Interleukin-3, 5 and GM-CSF signaling | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MASTL Facilitates Mitotic Progression | |
| Mitotic Prometaphase | |
| mRNA Capping | |
| NCAM signaling for neurite out-growth | |
| Neurophilin interactions with VEGF and VEGFR | |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
| NGF-independant TRKA activation | |
| Non-integrin membrane-ECM interactions | |
| NoRC negatively regulates rRNA expression | |
| NOTCH1 Intracellular Domain Regulates Transcription | |
| Nuclear Pore Complex (NPC) Disassembly | |
| Oxidative Stress Induced Senescence | |
| Pausing and recovery of HIV elongation | |
| Pausing and recovery of Tat-mediated HIV elongation | |
| Phosphorylation of Emi1 | |
| Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
| Phosphorylation of the APC/C | |
| PI3K events in ERBB2 signaling | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| PKA activation | |
| PKA activation in glucagon signalling | |
| PKA-mediated phosphorylation of CREB | |
| PKA-mediated phosphorylation of key metabolic factors | |
| PLC-gamma1 signalling | |
| PLCG1 events in ERBB2 signaling | |
| PPARA activates gene expression | |
| Rap1 signalling | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Recycling pathway of L1 | |
| Regulation by c-FLIP | |
| Regulation of actin dynamics for phagocytic cup formation | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| Regulation of insulin secretion | |
| Regulation of KIT signaling | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Resolution of Sister Chromatid Cohesion | |
| Retrograde neurotrophin signalling | |
| RIP-mediated NFkB activation via ZBP1 | |
| RNA Pol II CTD phosphorylation and interaction with CE | |
| RNA Polymerase I Chain Elongation | |
| RNA Polymerase I Promoter Escape | |
| RNA Polymerase I Transcription Initiation | |
| RNA Polymerase I Transcription Termination | |
| RNA Polymerase II HIV Promoter Escape | |
| RNA Polymerase II Pre-transcription Events | |
| RNA Polymerase II Promoter Escape | |
| RNA Polymerase II Transcription Elongation | |
| RNA Polymerase II Transcription Initiation | |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
| Role of Abl in Robo-Slit signaling | |
| Sema4D induced cell migration and growth-cone collapse | |
| Sema4D mediated inhibition of cell attachment and migration | |
| Separation of Sister Chromatids | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal transduction by L1 | |
| Signaling by BMP | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by Hippo | |
| Signaling by PDGF | |
| Signaling by SCF-KIT | |
| Signalling to p38 via RIT and RIN | |
| Signalling to RAS | |
| Signalling to STAT3 | |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
| Spry regulation of FGF signaling | |
| Tat-mediated elongation of the HIV-1 transcript | |
| Tat-mediated HIV elongation arrest and recovery | |
| Tie2 Signaling | |
| TNF signaling | |
| Transcription of the HIV genome | |
| Transcriptional regulation of white adipocyte differentiation | |
| TRIF-mediated programmed cell death | |
| TRKA activation by NGF | |
| TRP channels | |
| Vasopressin regulates renal water homeostasis via Aquaporins | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.